By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

Science Briefing

Science Briefing

Science Briefing

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Medicine - Today’s Neurology Science Briefing | April 30th 2026, 9:00:06 am

Medicine

Today’s Neurology Science Briefing | April 30th 2026, 9:00:06 am

Last updated: April 30, 2026 7:44 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

Key Highlights

•
Getting a two-dose recombinant zoster vaccine (shingles shot) was linked to a 33% lower risk of developing dementia and a 28% lower risk of Alzheimer’s disease in a large study of US adults aged 65 and older. This finding suggests that the vaccine may offer a powerful, safe way to help protect the aging brain and reduce the burden of these devastating neurological conditions.
Source →

•
By creating “mini-brains” (neurospheres) from the urine cells of patients with Dravet syndrome, a severe childhood epilepsy, researchers discovered unique protein patterns in the brain cells that correlate with how severe the patient’s symptoms are. This breakthrough provides a new, non-invasive way to study individual differences in this rare disease and could pave the way for personalized treatments.
Source →

•
Using a new type of DNA sequencing that reads very long stretches of DNA, scientists were able to find hidden “jumping gene” deletions that cause TANGO2 deficiency disorder, a condition that leads to serious neurological and metabolic problems. This advanced technology provides a more complete diagnosis for families with this disorder and could be used to find the genetic cause of many other undiagnosed brain conditions.
Source →


Stay curious. Stay informed — with
Science Briefing.

Always double check the original article for accuracy.


Reset My Briefings

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article Today’s Renewable Energy Science Briefing | April 30th 2026, 9:00:06 am
Next Article Today’s Political Science Science Briefing | April 30th 2026, 9:00:06 am
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

The Genetic Architecture of Oxytocin and Vasotocin: A New Frontier in Immune-Psychiatric Links

From Genes to Diagnosis: Polygenic Risk Scores Enter the Arena for Peripheral Artery Disease

Today’s Public Health Science Briefing | April 30th 2026, 9:00:06 am

A new study found that combining two treatments—one that fixes the faulty SMN2 gene and another that blocks an enzyme called HDAC6—greatly improved muscle strength and survival in a mouse model of spinal muscular atrophy (SMA). This is important because it offers a potential way to help SMA patients who still face muscle weakness even after receiving newer gene therapies.

Science Briefing

Tumour DNA Holds the Key to Classifying Hereditary Cancer Risk

This week’s Medicine Key Highlights

Targeting a Cellular Pathway to Protect the Lungs from Inflammatory Damage

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Energy
  • Gastroenterology
  • Surgery
  • Uncategorized
  • Chemistry
  • Natural Language Processing
  • Engineering

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?